Algo version: 0.98b
GlaxoSmithKline PLC is listed at the LSE Exchange
GlaxoSmithKline PLC [GSK.L]
LSE Sector: Industry:Pharmaceuticals, Biotechnology & Life Sciences

Is GlaxoSmithKline PLC stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, GlaxoSmithKline PLC pays dividends. Last time was Thursday 10th of October 2024 where the investors holding the stock on Thursday 15th of August 2024 were paid GBP15 per share. Over the last 111 times between 1993 and 2024, GlaxoSmithKline PLC has paid GBP1752.75 with an average of GBP15.79 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for GlaxoSmithKline PLC 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was GBP1 696.10, you would have made a loss of GBP-44.60 per share or -2.63%

Yes, the average daily trading liquidity for GlaxoSmithKline PLC is GBP7.17 million. You should therefore be able to get in and out of your positions relatively fast.

GlaxoSmithKline PLC has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.42, the company's ability to pay off the debt is normal. GlaxoSmithKline PLC has a good net profit margin of 14.59% and should have high tolerances against inflation.

We have calculated the inflation risk for GlaxoSmithKline PLC to be low [0.4 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.